PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35567986-0	2022	Procyanidins and its metabolites by gut microbiome improves insulin resistance in gestational diabetes mellitus mice model via regulating NF-kappaB and NLRP3 inflammasome pathway.	Proanthocyanidins	0-12	nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105	Mus musculus	138-147	
35567986-0	2022	Procyanidins and its metabolites by gut microbiome improves insulin resistance in gestational diabetes mellitus mice model via regulating NF-kappaB and NLRP3 inflammasome pathway.	Proanthocyanidins	0-12	NLR family, pyrin domain containing 3	Mus musculus	152-157	
35567986-8	2022	PA inhibited inflammation by decreasing the levels of IL-6, TNF-alpha, IL-17 and CRP, which also been blocked in the IFD mice.	Proanthocyanidins	0-2	interleukin 6	Mus musculus	54-58	
35567986-8	2022	PA inhibited inflammation by decreasing the levels of IL-6, TNF-alpha, IL-17 and CRP, which also been blocked in the IFD mice.	Proanthocyanidins	0-2	tumor necrosis factor	Mus musculus	60-69	
35567986-8	2022	PA inhibited inflammation by decreasing the levels of IL-6, TNF-alpha, IL-17 and CRP, which also been blocked in the IFD mice.	Proanthocyanidins	0-2	interleukin 17A	Mus musculus	71-76	
35567986-8	2022	PA inhibited inflammation by decreasing the levels of IL-6, TNF-alpha, IL-17 and CRP, which also been blocked in the IFD mice.	Proanthocyanidins	0-2	C-reactive protein, pentraxin-related	Mus musculus	81-84	
35567986-10	2022	Mechanistically, PA treatment suppressed the nuclear factor-kappaB (NF-kappaB) p65 nuclear translocation and nucleotide-binding domain like receptor protein 3 (NLRP3) inflammasome activation.	Proanthocyanidins	17-19	nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105	Mus musculus	45-66	
35567986-10	2022	Mechanistically, PA treatment suppressed the nuclear factor-kappaB (NF-kappaB) p65 nuclear translocation and nucleotide-binding domain like receptor protein 3 (NLRP3) inflammasome activation.	Proanthocyanidins	17-19	nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105	Mus musculus	68-77	
35567986-10	2022	Mechanistically, PA treatment suppressed the nuclear factor-kappaB (NF-kappaB) p65 nuclear translocation and nucleotide-binding domain like receptor protein 3 (NLRP3) inflammasome activation.	Proanthocyanidins	17-19	v-rel reticuloendotheliosis viral oncogene homolog A (avian)	Mus musculus	79-82	
35567986-10	2022	Mechanistically, PA treatment suppressed the nuclear factor-kappaB (NF-kappaB) p65 nuclear translocation and nucleotide-binding domain like receptor protein 3 (NLRP3) inflammasome activation.	Proanthocyanidins	17-19	NLR family, pyrin domain containing 3	Mus musculus	109-158	
35567986-10	2022	Mechanistically, PA treatment suppressed the nuclear factor-kappaB (NF-kappaB) p65 nuclear translocation and nucleotide-binding domain like receptor protein 3 (NLRP3) inflammasome activation.	Proanthocyanidins	17-19	NLR family, pyrin domain containing 3	Mus musculus	160-165	
35567986-11	2022	In vitro studies, 4-hydroxyphenylacetic acid and 3-(4-hydroxyphenyl) propionic acid, main intestinal flora metabolites of PA restrained NF-kappaB/NLRP3 activation.	4-hydroxyphenylacetic acid	18-44	nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105	Mus musculus	136-145	
35567986-11	2022	In vitro studies, 4-hydroxyphenylacetic acid and 3-(4-hydroxyphenyl) propionic acid, main intestinal flora metabolites of PA restrained NF-kappaB/NLRP3 activation.	4-hydroxyphenylacetic acid	18-44	NLR family, pyrin domain containing 3	Mus musculus	146-151	
35567986-11	2022	In vitro studies, 4-hydroxyphenylacetic acid and 3-(4-hydroxyphenyl) propionic acid, main intestinal flora metabolites of PA restrained NF-kappaB/NLRP3 activation.	phloretic acid	49-83	nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105	Mus musculus	136-145	
35567986-11	2022	In vitro studies, 4-hydroxyphenylacetic acid and 3-(4-hydroxyphenyl) propionic acid, main intestinal flora metabolites of PA restrained NF-kappaB/NLRP3 activation.	phloretic acid	49-83	NLR family, pyrin domain containing 3	Mus musculus	146-151	
35567986-11	2022	In vitro studies, 4-hydroxyphenylacetic acid and 3-(4-hydroxyphenyl) propionic acid, main intestinal flora metabolites of PA restrained NF-kappaB/NLRP3 activation.	Proanthocyanidins	122-124	NLR family, pyrin domain containing 3	Mus musculus	146-151	
35567986-12	2022	In conclusions, PA improved IR via NF-kappaB/NLRP3 pathway in GDM and postpartum mice, which partly through its metabolites by gut microbiome.	Proanthocyanidins	16-18	nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105	Mus musculus	35-44	
35567986-12	2022	In conclusions, PA improved IR via NF-kappaB/NLRP3 pathway in GDM and postpartum mice, which partly through its metabolites by gut microbiome.	Proanthocyanidins	16-18	NLR family, pyrin domain containing 3	Mus musculus	45-50